Shares of HIMS experienced a dramatic decline today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by nearly 20%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that it c